Novozymes A/S (OTCMKTS:NVZMY) Sees Unusually-High Trading Volume – Should You Buy?

Novozymes A/S (OTCMKTS:NVZMY) saw an uptick in trading volume on Thursday . 81,093 shares were traded during mid-day trading, an increase of 106% from the previous session’s volume of 39,338 shares.The stock last traded at $63.4280 and had previously closed at $61.67.

Wall Street Analyst Weigh In

Separately, Zacks Research downgraded shares of Novozymes A/S from a “strong-buy” rating to a “hold” rating in a report on Monday, August 25th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Novozymes A/S Trading Up 0.2%

The firm has a market cap of $29.65 billion, a price-to-earnings ratio of 37.46, a price-to-earnings-growth ratio of 1.25 and a beta of 1.08. The business has a 50 day moving average of $62.32 and a 200 day moving average of $65.35. The company has a quick ratio of 1.00, a current ratio of 1.61 and a debt-to-equity ratio of 0.26.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).